Primary |
Asthma |
40.4% |
Drug Use For Unknown Indication |
19.2% |
Cough |
7.1% |
Product Used For Unknown Indication |
7.1% |
Asthma Prophylaxis |
4.0% |
Infection |
4.0% |
Atrial Fibrillation |
2.0% |
Bronchitis |
2.0% |
Epilepsy |
2.0% |
Hormone Replacement Therapy |
2.0% |
Hypertension |
2.0% |
Hypothyroidism |
2.0% |
Inflammation |
2.0% |
Blood Pressure Increased |
1.0% |
Prostatomegaly |
1.0% |
Seasonal Allergy |
1.0% |
Sedation |
1.0% |
|
Throat Irritation |
10.3% |
Dysgeusia |
8.6% |
Muscle Spasms |
8.6% |
Wheezing |
8.6% |
Cough |
6.9% |
Rash |
6.9% |
Asthma |
5.2% |
Oropharyngeal Pain |
5.2% |
Product Quality Issue |
5.2% |
Burning Sensation |
3.4% |
Chest Discomfort |
3.4% |
Malaise |
3.4% |
Multiple Sclerosis |
3.4% |
Nausea |
3.4% |
Skin Atrophy |
3.4% |
Swelling Face |
3.4% |
Throat Tightness |
3.4% |
Urticaria |
3.4% |
Bronchospasm |
1.7% |
Convulsion |
1.7% |
|
Secondary |
Asthma |
55.6% |
Atrial Fibrillation |
22.2% |
Hypothyroidism |
11.1% |
Prostatomegaly |
11.1% |
|
Polyuria |
33.3% |
Swelling Face |
33.3% |
Therapeutic Response Unexpected |
33.3% |
|
Concomitant |
Product Used For Unknown Indication |
56.2% |
Asthma |
14.6% |
Hypertension |
6.2% |
Drug Use For Unknown Indication |
3.4% |
Urinary Tract Infection |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Pain |
1.6% |
Prophylaxis |
1.6% |
Dyspepsia |
1.5% |
Seasonal Allergy |
1.5% |
Atrial Fibrillation |
1.3% |
Lower Respiratory Tract Infection |
1.3% |
Myocardial Ischaemia |
1.3% |
Osteoarthritis |
1.1% |
Postoperative Care |
1.0% |
Depression |
0.8% |
Herpes Zoster |
0.8% |
Type 2 Diabetes Mellitus |
0.8% |
Anticoagulant Therapy |
0.6% |
Constipation |
0.6% |
|
Oedema Peripheral |
8.4% |
Pulmonary Fibrosis |
7.4% |
Somnambulism |
7.4% |
Migraine |
6.3% |
Syncope |
6.3% |
Dyspnoea |
5.3% |
Myalgia |
5.3% |
Rash |
5.3% |
Sleep Disorder |
5.3% |
Tendonitis |
5.3% |
Dry Skin |
4.2% |
Paraesthesia |
4.2% |
Pneumonia |
4.2% |
Poor Quality Sleep |
4.2% |
Renal Failure Acute |
4.2% |
Vomiting |
4.2% |
Dermatitis Bullous |
3.2% |
Drug Exposure During Pregnancy |
3.2% |
Rectal Haemorrhage |
3.2% |
Vision Blurred |
3.2% |
|
Interacting |
Atrial Fibrillation |
37.8% |
Asthma |
18.9% |
Hypothyroidism |
18.9% |
Prostatomegaly |
18.9% |
Product Used For Unknown Indication |
5.4% |
|
Therapeutic Response Unexpected |
100.0% |
|